Judy Keen named ASTRO director of scientific affairs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JUDY KEEN was named director of scientific affairs of the American Society for Radiation Oncology.

Keen will work to develop and implement initiatives that promote clinical, translational and basic radiation research, with the ultimate goal of advancing both science and evidence-based patient care throughout the radiation oncology community—including managing various funding mechanisms offered by ASTRO, such as its junior faculty awards and seed grants, as well as finding and promoting opportunities from external funding agencies to share with ASTRO members.

Keen will also serve as ASTRO’s primary scientific liaison to internal and external partners involved in biomedical research, including the ASTRO Science Council, federal agencies, other medical societies, coalitions, the biopharmaceutical industry, and policymakers.

Prior to joining ASTRO, Keen was director of research collaborations for the National Breast Cancer Coalition. Before NBCC, she worked at NCI, first as a health science analyst in the Office of Science Planning and Assessment, then as program director for the NIH Genotype Tissue Expression project within the Biorepository and Biospecimen Research Branch. The GTEx project included curating a collection of genomic and clinical data from more than 900 donors that was designed to explore genetic variability in humans and the changes that lead to disease.

Keen also spent several years as an assistant professor in the department of medicine at the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey.

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login